CareTrust REIT (NYSE:CTRE) Price Target Raised to $46.00

Key Points

• UBS raised its CareTrust REIT price target to $46 from $44 and maintained a Buy rating, implying about 19.1% upside from the stock’s cited price.
• Analyst sentiment is broadly positive: MarketBeat reports a consensus Moderate Buy rating and an average target of $43.71, though some firms have issued Hold or Sell ratings.
• CareTrust reported quarterly EPS of $0.54, beating the $0.52 consensus estimate; shares fell 0.6% on Wednesday to $38.62.

CareTrust REIT (NYSE:CTRE - Get Free Report) had its target price increased by research analysts at UBS Group from $44.00 to $46.00 in a research report issued on Wednesday, Benzinga reports. The brokerage currently has a "buy" rating on the stock. UBS Group's price target suggests a potential upside of 19.10% from the company's current price.

CTRE has been the subject of several other research reports. Royal Bank Of Canada reissued a "sector perform" rating and set a $43.00 price target on shares of CareTrust REIT in a research report on Monday, October 5th. Wall Street Zen cut shares of CareTrust REIT from a "hold" rating to a "sell" rating in a research report on Saturday. BMO Capital Markets lowered their price objective on shares of CareTrust REIT from $47.00 to $45.00 and set an "outperform" rating for the company in a research note on Monday, October 5th. Weiss Ratings lowered shares of CareTrust REIT from a "buy (b+)" rating to a "buy (b)" rating in a report on Monday, October 12th. Finally, Huntington began coverage on shares of CareTrust REIT in a report on Thursday, September 10th. They set an "outperform" rating and a $44.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and four have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $43.71.

CareTrust REIT Trading Down 0.6%

CTRE stock traded down $0.22 during trading on Wednesday, hitting $38.62. 1,048,987 shares of the company traded hands, compared to its average volume of 2,548,408. The firm has a market capitalization of $9.95 billion, a PE ratio of 24.29, a P/E/G ratio of 1.38 and a beta of 0.77. CareTrust REIT has a 1 year low of $34.74 and a 1 year high of $43.62. The company has a 50-day moving average of $37.27 and a 200-day moving average of $39.00. The company has a debt-to-equity ratio of 0.39, a quick ratio of 3.08 and a current ratio of 3.08.

CareTrust REIT (NYSE:CTRE - Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.02. CareTrust REIT had a return on equity of 8.08% and a net margin of 59.18%. The firm had revenue of $176.36 million during the quarter. Analysts predict that CareTrust REIT will post 2.07 earnings per share for the current fiscal year.

Institutional Trading of CareTrust REIT

Several large investors have recently added to or reduced their stakes in the stock. Persistent Asset Partners Ltd bought a new position in CareTrust REIT in the 2nd quarter worth $31,000. Compass Financial Management LLC purchased a new stake in shares of CareTrust REIT in the 2nd quarter worth about $34,000. Signature Equity Partners LLC boosted its stake in shares of CareTrust REIT by 37.8% during the 3rd quarter. Signature Equity Partners LLC now owns 1,393 shares of the company's stock valued at $51,000 after purchasing an additional 382 shares in the last quarter. Burnham & Co LLC bought a new stake in shares of CareTrust REIT during the 2nd quarter valued at about $61,000. Finally, Allworth Financial LP bought a new stake in shares of CareTrust REIT during the 2nd quarter valued at about $66,000. Institutional investors own 87.77% of the company's stock.

Key CareTrust REIT News

Investors following CTRE have been watching these news items:

• Positive Sentiment: Huntington reiterated an Outperform rating and a $44 price target. Its estimates project EPS growth from $2.05 in FY2026 to $2.31 in FY2027 and $2.43 in FY2028, suggesting an improving earnings outlook. The FY2026 estimate is slightly below the cited $2.07 consensus, tempering the near-term signal. MarketBeat coverage
• Neutral Sentiment: A separate article discusses CTRE in the context of rotational-strategy timing, but the provided headline does not disclose a specific recommendation or catalyst. How CareTrust REIT Affects Rotational Strategy Timing

CareTrust REIT Company Profile

CareTrust REIT, Inc. is a real estate investment trust that owns and invests in healthcare-related properties, with a focus on skilled nursing facilities and senior housing. Its portfolio also includes assisted living and other properties that serve older adults and people requiring healthcare services. The company primarily works with healthcare operators through long-term property leases and other real estate investments. CareTrust's properties are located across the United States, and the company has expanded its investments into the United Kingdom.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.